JPS6317842B2 - - Google Patents
Info
- Publication number
- JPS6317842B2 JPS6317842B2 JP7657379A JP7657379A JPS6317842B2 JP S6317842 B2 JPS6317842 B2 JP S6317842B2 JP 7657379 A JP7657379 A JP 7657379A JP 7657379 A JP7657379 A JP 7657379A JP S6317842 B2 JPS6317842 B2 JP S6317842B2
- Authority
- JP
- Japan
- Prior art keywords
- polysaccharide
- vegetable
- gum
- acid
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229920001282 polysaccharide Polymers 0.000 claims description 34
- 239000005017 polysaccharide Substances 0.000 claims description 34
- 150000004676 glycans Chemical class 0.000 claims description 29
- 235000013311 vegetables Nutrition 0.000 claims description 21
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 17
- -1 polysaccharide sulfate ester Chemical class 0.000 claims description 16
- KEQGZUUPPQEDPF-UHFFFAOYSA-N 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC1(C)N(Cl)C(=O)N(Cl)C1=O KEQGZUUPPQEDPF-UHFFFAOYSA-N 0.000 claims description 15
- XTHPWXDJESJLNJ-UHFFFAOYSA-N chlorosulfonic acid Substances OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 claims description 15
- 241000196324 Embryophyta Species 0.000 claims description 10
- MQFLXLMNOHHPTC-UHFFFAOYSA-N 1-isothiocyanato-9-(methylsulfinyl)nonane Chemical group CS(=O)CCCCCCCCCN=C=S MQFLXLMNOHHPTC-UHFFFAOYSA-N 0.000 claims description 9
- 230000032050 esterification Effects 0.000 claims description 9
- 238000005886 esterification reaction Methods 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 241000416162 Astragalus gummifer Species 0.000 claims description 6
- 229920001615 Tragacanth Polymers 0.000 claims description 6
- 150000002148 esters Chemical class 0.000 claims description 3
- 235000010487 tragacanth Nutrition 0.000 claims description 3
- 239000000196 tragacanth Substances 0.000 claims description 3
- 229940116362 tragacanth Drugs 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000000047 product Substances 0.000 description 7
- 150000003512 tertiary amines Chemical class 0.000 description 7
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 235000019441 ethanol Nutrition 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 229920001938 Vegetable gum Polymers 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 230000023555 blood coagulation Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 3
- 244000215068 Acacia senegal Species 0.000 description 3
- 229920000084 Gum arabic Polymers 0.000 description 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- 239000000205 acacia gum Substances 0.000 description 3
- 235000010489 acacia gum Nutrition 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 230000002429 anti-coagulating effect Effects 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 229940127219 anticoagulant drug Drugs 0.000 description 3
- 239000004019 antithrombin Substances 0.000 description 3
- 230000015271 coagulation Effects 0.000 description 3
- 238000005345 coagulation Methods 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 229960002897 heparin Drugs 0.000 description 3
- 239000003456 ion exchange resin Substances 0.000 description 3
- 229920003303 ion-exchange polymer Polymers 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 2
- 244000144730 Amygdalus persica Species 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- PTHCMJGKKRQCBF-UHFFFAOYSA-N Cellulose, microcrystalline Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC)C(CO)O1 PTHCMJGKKRQCBF-UHFFFAOYSA-N 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- AEMOLEFTQBMNLQ-DTEWXJGMSA-N D-Galacturonic acid Natural products O[C@@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-DTEWXJGMSA-N 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- 108090000190 Thrombin Proteins 0.000 description 2
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000002402 anti-lipaemic effect Effects 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- AEMOLEFTQBMNLQ-UHFFFAOYSA-N beta-D-galactopyranuronic acid Natural products OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 2
- 229940059329 chondroitin sulfate Drugs 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 239000004570 mortar (masonry) Substances 0.000 description 2
- 229960004072 thrombin Drugs 0.000 description 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 244000228088 Cola acuminata Species 0.000 description 1
- 235000010205 Cola acuminata Nutrition 0.000 description 1
- 235000015438 Cola nitida Nutrition 0.000 description 1
- 244000107602 Corymbia citriodora Species 0.000 description 1
- QXKAIJAYHKCRRA-JJYYJPOSSA-N D-arabinonic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C(O)=O QXKAIJAYHKCRRA-JJYYJPOSSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- SHZGCJCMOBCMKK-PQMKYFCFSA-N L-Fucose Natural products C[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O SHZGCJCMOBCMKK-PQMKYFCFSA-N 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241001494501 Prosopis <angiosperm> Species 0.000 description 1
- 235000001560 Prosopis chilensis Nutrition 0.000 description 1
- 235000014460 Prosopis juliflora var juliflora Nutrition 0.000 description 1
- 241000196435 Prunus domestica subsp. insititia Species 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 244000111306 Torreya nucifera Species 0.000 description 1
- 235000006732 Torreya nucifera Nutrition 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- UZUODNWWWUQRIR-UHFFFAOYSA-L disodium;3-aminonaphthalene-1,5-disulfonate Chemical compound [Na+].[Na+].C1=CC=C(S([O-])(=O)=O)C2=CC(N)=CC(S([O-])(=O)=O)=C21 UZUODNWWWUQRIR-UHFFFAOYSA-L 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 125000001174 sulfone group Chemical group 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Description
本発明は植物性多糖類硫酸エステルの製造法に
関するものである。詳しくは、植物性ゴム質から
得られる植物性多糖類の新規な硫酸エステルの製
造法に関するものである。
ヘパリン、コンドロイチン硫酸等の動物性ムコ
多糖は多糖の硫酸エステルであるが、糖残基にグ
ルコサミンをもち、またカルボキシル基も有する
などたいへんに複雑な構造である。このため、ヘ
パリン、コンドロイチン硫酸等は血液凝固阻止作
用および抗脂血作用等の生理活性を示す医薬品等
として広い用途を有しているにも拘わらず、その
製造は依然として動物の肺や腸粘膜からの抽出に
頼らざるを得ず、その供給が限られているといつ
た欠点がある。
一方、植物がゴム質として分泌するものも、多
くは多糖類であり、現在知られているだけでも数
十種類にものぼる。その構造として、多くはD−
グルクロン酸またはD−ガラクツロン酸および他
の中性糖残基が結合した一種のポリウロナイドで
あり、動物性ムコ多糖よりも単純な構造で、その
入手も容易である。
これらの事情に鑑み、本発明者等は血液凝固作
用を有する新らたな化合物を得るべく鋭意研究し
たところ、植物ゴム質から得られる植物性多糖類
を硫酸エステル化して得られる植物性多糖類硫酸
エステルがその目的に好適なことを見出し、本発
明に到達した。
以下に本発明を詳細に説明する。
植物性ゴム質は良く知られた物質で、植物の茎
や果実が傷を受けた場合、または自然のままで分
泌されて凝固し、傷口を保護するもので、その主
成分は多糖類である。
植物性ゴム質としては、アラビアゴム、トラガ
カントゴム、メスキートゴム、ダムソンゴム、サ
クラゴム、セイヨウスモモゴム、アーモンドゴ
ム、モモゴム、レモンゴム、ブドウゴム、コラゴ
ム、ガツテイゴム、カラヤゴム、カーヤゴム、ミ
ルゴム等が知られており、これらの植物性ゴムの
中ではアラビアゴムおよびトラガカントゴムが入
手しやすい点等で有利である。
これらの植物性ゴムの中には、それぞれの種類
に対応する植物性多糖類が含まれており、例えば
アラビアゴム中にはアラビン(アラビン酸)、ト
ラガカントゴム中にはトラガカント(トラガカン
ト酸)がある。これらの植物性多糖類は、それぞ
れ周知の方法によつて植物性ゴムから分離・精製
することができる。
アラビンは、D−グルクロン酸13.8%、D−ガ
ラクトース36.8%、L−アラビノース30.3%およ
びL−ラムノース11.4%等により構成され、それ
らの結合様式や構造の一部は知られている。
また、トラガカントはD−ガラクツロン酸43
%、D−キシロース40%およびその他L−フコー
スを含む複合多糖類である。
これらの植物性多糖類の硫酸エステル化は、常
法によつて行うことができる。
植物性多糖類は、硫酸エステル化の前に微粉化
しておくことが好ましい。微粉化しておけば、次
の工程の反応速度が上り、好ましい結果を与え
る。
硫酸エステル化は、通常、植物性多糖類をクロ
ロスルホン酸と反応させることにより行われる。
硫酸エステル化をクロロスルホン酸で行う場合
には、植物性多糖類をピリジン等の三級アミンに
懸濁させ、次いでクロロスルホン酸を加えればよ
い。
三級アミンの量は、植物性多糖類に対し通常5
〜10倍(重量)量である。三級アミンの量が少な
すぎると反応が急激に進みクロロスルホン酸によ
り植物性多糖類の分解をきたし、また三級アミン
の量が多すぎてもクロロスルホン酸と三級アミン
の複合物が溶媒量に対して少なすぎるために反応
の進行が遅く目的とする多糖の硫酸エステル化物
が生成しにくいため好ましくない。
クロロスルホン酸の量は、植物性多糖類に対し
通常1〜2倍(重量)である。クロロスルホン酸
の量が少なすぎると多糖硫酸エステルの生成が十
分に進行せず、またクロロスルホン酸の量が多す
ぎても反応物及び生成物の分解を伴なうので何れ
も好ましくない。
クロロスルホン酸を、植物性多糖類の三級アミ
ン懸濁液に添加する際の温度は、通常−10〜10℃
である。この温度が低すぎると反応が十分に進行
せず硫酸エステル化が進みにくいし、また温度が
高すぎるとクロロスルホン酸による多糖の分解が
おこるので何れも好ましくない。
クロロスルホン酸の添加が終了した後は反応温
度を上げ、通常60〜100℃とする。この温度が低
すぎるとクロロスルホン酸と三級アミンとの複合
体の反応性が悪く、また温度が高すぎると溶媒の
沸点近くになり反応操作に支障をきたすので何れ
も好ましくない。
反応中は激しく撹拌しておくことが好ましい。
反応時間は、種々の反応条件により相違するの
で、生成物の生理活性等を測定しながら、適宜決
定すればよい。
こうして生成した植物性多糖類の硫酸エステル
は、常法により後処理し、精製・単離することが
できる。すなわち、例えばゲルロ過やイオン交換
樹脂処理を適宜組み合わせて用いることにより植
物性多糖類の硫酸エステルを単離し、アルカリで
中和して濃縮し、アルコールを加えれば植物性多
糖類の硫酸エステルのアルカリ金属塩が得られ
る。
生成する植物性多糖類の硫酸エステル中の硫酸
エステル化の程度は、原料の植物性多糖類中の水
酸基に対する生成物中のスルホン基の比として、
通常0.3〜1、好ましくは0.33〜0.67である。硫酸
エステル化の程度が前記の範囲であれば抗血液凝
固作用が高いので好ましい。
生成した植物性多糖類の硫酸エステルは、抗血
液凝固作用、抗脂血作用を有し、医薬品として使
用しうる。抗血液凝固剤等としての使用法は、従
来周知のヘパリン等と同様である。
以下に実施例を挙げて、本発明を更に詳細に説
明するが、本発明はその要旨を超えない限り以下
の実施例により限定を受けるものではない。
実施例 1
市販アラビン2.0gを、ピリジン(20ml)中に
懸濁させる。
懸濁液を−10℃に冷却し、激しく撹拌する。撹
拌下クロロスルフオン酸(6.8g)を徐々に30分
間で滴下し、温度を0℃に保つ。反応混合物を室
温に放置し、次に80℃に加熱する。3時間後、反
応を終了し、室温にまで温度をもどす。
反応混合物に20mlの水を加え、水溶液とする。
これを、あらかじめ調整しておいたセルロースゲ
ル〔フアルマシアフアインケミカルズ社商標セフ
アデツクス(Sephadex)〕G25、360mlのカラム
を通し、水溶媒で溶出して各フラクシヨンに分け
る。抗スロンビン活性度を測定し、活性部を集め
る。活性部分を減圧濃縮し、濃縮液(20ml)をさ
きに調整しておいた強酸性イオン交換樹脂カラム
(三菱化成工業社登録商標“ダイヤイオン”SK
#1、H型)を通し、水溶出液のうち酸性部分を
集め、脱色炭処理を行い、脱色された溶液を水酸
化ナトリウムで中和して、目的とする多糖類硫酸
エステル塩を得る。中和液に20倍量のメタノール
もしくはエタノール等のアルコールを加え、生成
物の沈澱を得る。
沈澱をロ過により採取し、さらにアルコール、
エーテルによつて洗浄し、加熱乾燥を行い、粉砕
をして、目的とするアラビン硫酸エステル塩を得
る。
収量 65%、元素分析 C15.94% H2.62%
灰分 35.83%
赤外吸収スペクトル図を第1図に示した。
実施例 2
市販トラガカント酸2.0gを乳鉢中でよく、粉
砕し、粉末をピリジン(40ml)中に懸濁させ、激
しく撹拌する。
懸濁液を−10℃に冷却し、滴下ロートにてクロ
ロスルホン酸(6.3g)を30分間で滴下する。こ
の時、温度は0℃以下に保ち、激しく撹拌を続け
る。滴下終了後、反応液を室温にもどし、さらに
100℃に加熱して5時間反応させる。
反応終了後40mlの水を加えて水溶液とし、さら
に800mlのエチルアルコールを加えて反応混合物
の沈澱を得る。
沈澱物をロ過によつて集め、20mlの水に溶解す
る。あらかじめ実施例1と同様なセルロースゲル
のカラム(径3.0cm、長さ37cm)を調整しておき、
反応物の混合液をカラムに通し、さらに水にて溶
出させ、各フラクシヨンを10mlずつとる。各フラ
クシヨンに対して抗スロビン活性部分だけとり、
さらに減圧濃縮し、全量を20mlとする。この水溶
液20mlを、イオン交換樹脂(三菱化成工業社登録
商標“ダイヤイオン”SK#1、H型)カラム
(径3.5cm、長さ20cm)に通して水で溶出し、酸性
溶出部分をとる。酸性溶液を水酸化ナトリウムで
中和し、中和溶液を減圧濃縮し、全量を20mlと
し、活性炭処理をする。濃縮液中に20倍量のエタ
ノール、もしくはメタノールを加えてトラガカン
ト酸の硫酸エステル塩を析出させる。
ロ過によりこの生成物をとり、さらにメタノー
ル、エーテルで生成物を洗浄し、加熱乾燥後、乳
鉢で粉砕してトラガカント酸硫酸エステル塩を得
る。
収量 63.5% 元素分析 C:10.56% H2.27
% 灰分 45.85%
赤外吸収スペクトル図を第2図に示した。
以上のごとく得られた、植物性多糖類硫酸エス
テルの生理活性は、次に示すごとくである。
すなわち、ヘパリン様活性をしらべるため、牛
プラズマとスロンビンによる血液凝固反応系にお
いて、上で得られた多糖誘導体を検討した。抗ス
ロンビン作用および全血凝固時間に対する効果抗
スロンビン作用を調べるために牛クエン酸血漿
0.1mlに試料水溶液0.1mlを加えて、37℃に30秒間
保温した後、持田製薬社製スロンビン溶液0.1ml
を添加して37℃に保温し、フイブリン糸が析出す
るまでの時間を凝固時間として測定した。試料無
添加での凝固時間を20秒とし、凝固時間を40秒に
するに要する試料濃度をI50として求めた。
全血凝固時間を測定するために、試料の生理食
塩水溶液0.01〜0.02mlにウサギ新鮮血を1ml加え
て、リー・ホワイト(Lee−White)法により凝
固時間を測定した。
結果を次表にした。
The present invention relates to a method for producing a vegetable polysaccharide sulfate. Specifically, the present invention relates to a method for producing a novel sulfate ester of a vegetable polysaccharide obtained from vegetable gum. Animal mucopolysaccharides such as heparin and chondroitin sulfate are sulfate esters of polysaccharides, but they have very complex structures, including glucosamine and carboxyl groups as sugar residues. For this reason, although heparin, chondroitin sulfate, etc. have a wide range of uses as pharmaceuticals that exhibit physiological activities such as anticoagulant and antilipidemic effects, they are still manufactured from the lungs and intestinal mucosa of animals. The disadvantage is that it has to rely on extraction, and its supply is limited. On the other hand, many of the rubbery substances secreted by plants are polysaccharides, and there are dozens of types that are currently known. Its structure is mostly D-
It is a type of polyuronide in which glucuronic acid or D-galacturonic acid and other neutral sugar residues are bonded, and it has a simpler structure than animal mucopolysaccharide and is easily available. In view of these circumstances, the present inventors conducted intensive research to obtain a new compound with blood coagulation effect, and found that a plant polysaccharide obtained by sulfuric acid esterification of a plant polysaccharide obtained from plant gums was found. It was discovered that sulfuric esters are suitable for this purpose, and the present invention was achieved. The present invention will be explained in detail below. Vegetable gum is a well-known substance that is secreted when the stem or fruit of a plant is injured, or is secreted naturally and solidifies to protect the wound, and its main component is polysaccharide. . Known vegetable gums include gum arabic, gum tragacanth, mesquite gum, damson gum, cherry gum, peach gum, almond gum, peach gum, lemon gum, grape gum, kola gum, gatsutei gum, karaya gum, kaya gum, and mil gum. Among vegetable gums, gum arabic and gum tragacanth are advantageous because they are easily available. These vegetable gums contain plant polysaccharides corresponding to their respective types; for example, gum arabic contains arabin (arabic acid), and gum tragacanth contains tragacanth (tragacanthic acid). Each of these vegetable polysaccharides can be separated and purified from vegetable rubber by well-known methods. Arabin is composed of 13.8% D-glucuronic acid, 36.8% D-galactose, 30.3% L-arabinose, 11.4% L-rhamnose, etc., and some of their bonding modes and structures are known. In addition, tragacanth is D-galacturonic acid 43
%, D-xylose 40% and other L-fucose. Sulfate esterification of these vegetable polysaccharides can be carried out by a conventional method. It is preferable that the vegetable polysaccharide is pulverized before sulfuric acid esterification. If it is pulverized, the reaction rate in the next step will be increased and a favorable result will be obtained. Sulfuric acid esterification is usually performed by reacting a vegetable polysaccharide with chlorosulfonic acid. When sulfuric acid esterification is performed using chlorosulfonic acid, the vegetable polysaccharide may be suspended in a tertiary amine such as pyridine, and then chlorosulfonic acid may be added. The amount of tertiary amine is usually 5% for vegetable polysaccharides.
~10 times the amount (by weight). If the amount of tertiary amine is too small, the reaction will proceed rapidly and the vegetable polysaccharide will be decomposed by chlorosulfonic acid, and if the amount of tertiary amine is too large, the complex of chlorosulfonic acid and tertiary amine will become a solvent. Since the amount is too small relative to the amount, the reaction progresses slowly and it is difficult to produce the desired sulfuric acid ester of polysaccharide, which is not preferable. The amount of chlorosulfonic acid is usually 1 to 2 times the amount (by weight) of the vegetable polysaccharide. If the amount of chlorosulfonic acid is too small, the production of polysaccharide sulfate ester will not proceed sufficiently, and if the amount of chlorosulfonic acid is too large, the reactants and products will be decomposed, which is not preferable. The temperature when adding chlorosulfonic acid to a tertiary amine suspension of vegetable polysaccharide is usually -10 to 10°C.
It is. If this temperature is too low, the reaction will not proceed sufficiently and sulfuric acid esterification will be difficult to proceed, and if the temperature is too high, the polysaccharide will be decomposed by chlorosulfonic acid, so neither is preferable. After the addition of chlorosulfonic acid is completed, the reaction temperature is raised, usually from 60 to 100°C. If this temperature is too low, the reactivity of the complex of chlorosulfonic acid and tertiary amine will be poor, and if the temperature is too high, the temperature will be close to the boiling point of the solvent, which will impede the reaction operation. It is preferable to stir vigorously during the reaction. Since the reaction time varies depending on various reaction conditions, it may be determined as appropriate while measuring the physiological activity of the product. The sulfuric acid ester of a vegetable polysaccharide thus produced can be post-treated, purified and isolated by a conventional method. That is, for example, by using an appropriate combination of gel filtration and ion exchange resin treatment, the sulfate ester of a vegetable polysaccharide is isolated, neutralized and concentrated with an alkali, and then alcohol is added to remove the alkali of the sulfate ester of a vegetable polysaccharide. A metal salt is obtained. The degree of sulfate esterification in the sulfate ester of the produced plant polysaccharide is determined as the ratio of the sulfone groups in the product to the hydroxyl groups in the raw material plant polysaccharide.
It is usually 0.3 to 1, preferably 0.33 to 0.67. It is preferable that the degree of sulfuric acid esterification is within the above range because the anticoagulant effect is high. The produced sulfate ester of plant polysaccharide has anticoagulant and antilipidemic effects and can be used as a pharmaceutical. The method of use as an anticoagulant and the like is the same as that of conventionally well-known heparin and the like. The present invention will be described in more detail with reference to Examples below, but the present invention is not limited by the Examples unless it exceeds the gist thereof. Example 1 2.0 g of commercial arabin are suspended in pyridine (20 ml). The suspension is cooled to −10° C. and stirred vigorously. While stirring, chlorosulfonic acid (6.8 g) was slowly added dropwise over 30 minutes, keeping the temperature at 0°C. The reaction mixture is left at room temperature and then heated to 80°C. After 3 hours, the reaction is completed and the temperature is returned to room temperature. Add 20 ml of water to the reaction mixture to make an aqueous solution.
This is passed through a 360 ml column of cellulose gel (Sephadex, a trademark of Pharmacia Fine Chemicals Co., Ltd.) G25, which has been prepared in advance, and eluted with a water solvent to separate into each fraction. Measure the antithrombin activity and collect the active part. The active part was concentrated under reduced pressure, and the concentrated solution (20 ml) was prepared using a strongly acidic ion exchange resin column (Mitsubishi Chemical Industries, Ltd. registered trademark "Diaion" SK).
The acidic portion of the aqueous eluate is collected and treated with decolorizing charcoal, and the decolorized solution is neutralized with sodium hydroxide to obtain the desired polysaccharide sulfate ester salt. Add 20 times the amount of alcohol such as methanol or ethanol to the neutralized solution to precipitate the product. The precipitate was collected by filtration and further mixed with alcohol,
The product is washed with ether, dried by heating, and pulverized to obtain the desired arabin sulfate ester salt. Yield 65%, elemental analysis C15.94% H2.62%
Ash content: 35.83% The infrared absorption spectrum is shown in Figure 1. Example 2 2.0 g of commercially available tragacanthic acid are ground well in a mortar, the powder is suspended in pyridine (40 ml) and stirred vigorously. The suspension was cooled to -10°C, and chlorosulfonic acid (6.3 g) was added dropwise over 30 minutes using a dropping funnel. At this time, the temperature is kept below 0°C and vigorous stirring is continued. After completing the dropwise addition, the reaction solution was returned to room temperature, and then
Heat to 100°C and react for 5 hours. After the reaction is completed, 40 ml of water is added to make an aqueous solution, and 800 ml of ethyl alcohol is further added to obtain a precipitate of the reaction mixture. The precipitate is collected by filtration and dissolved in 20 ml of water. A cellulose gel column (diameter 3.0 cm, length 37 cm) similar to that in Example 1 was prepared in advance.
Pass the reaction mixture through the column, elute with water, and take 10 ml of each fraction. Only the antithrobin active part is taken from each fraction.
Further concentrate under reduced pressure to bring the total volume to 20 ml. 20 ml of this aqueous solution is passed through an ion exchange resin (Mitsubishi Chemical Industries, Ltd. registered trademark "Diaion"SK#1, H type) column (diameter 3.5 cm, length 20 cm) and eluted with water, and the acidic eluted portion is taken. Neutralize the acidic solution with sodium hydroxide, concentrate the neutralized solution under reduced pressure to a total volume of 20 ml, and treat with activated carbon. Add 20 times the volume of ethanol or methanol to the concentrate to precipitate the sulfate ester salt of tragacanthic acid. The product is collected by filtration, washed with methanol and ether, dried by heating, and ground in a mortar to obtain tragacanthic acid sulfate. Yield 63.5% Elemental analysis C: 10.56% H2.27
% Ash content 45.85% The infrared absorption spectrum is shown in Figure 2. The physiological activity of the vegetable polysaccharide sulfate ester obtained as described above is as shown below. That is, in order to investigate heparin-like activity, the polysaccharide derivative obtained above was examined in a blood coagulation reaction system using bovine plasma and thrombin. Antithrombin effect and effect on whole blood clotting time Bovine citrate plasma to investigate antithrombin effect
Add 0.1 ml of sample aqueous solution to 0.1 ml, keep warm at 37℃ for 30 seconds, and add 0.1 ml of thrombin solution manufactured by Mochida Pharmaceutical Co., Ltd.
was added and kept at 37°C, and the time until fibrin threads precipitated was measured as the coagulation time. Assuming that the coagulation time without sample addition was 20 seconds, the sample concentration required to make the coagulation time 40 seconds was determined as I50 . To measure the whole blood clotting time, 1 ml of fresh rabbit blood was added to 0.01 to 0.02 ml of the saline sample solution, and the clotting time was measured by the Lee-White method. The results are shown in the table below.
【表】【table】
【表】
なお、実施例1および2において、水酸化ナト
リウムで中和する代りに水酸化バリウムで中和し
ても同様な結果が得られた。[Table] In Examples 1 and 2, similar results were obtained when neutralization was performed with barium hydroxide instead of with sodium hydroxide.
第1図および第2図は、実施例1および2の生
成物の赤外吸収スペクトル図である。
1 and 2 are infrared absorption spectra of the products of Examples 1 and 2.
Claims (1)
エステル化することを特徴とする植物性多糖類硫
酸エステルの製造法。 2 特許請求の範囲第1項記載の硫酸エステルの
製造法において、硫酸エステル化を、植物性多糖
類とクロロスルホン酸を反応させることにより行
うことを特徴とする方法。 3 特許請求の範囲第1項または第2項に記載の
硫酸エステルの製造法において、植物性多糖類が
アラビンであることを特徴とする方法。 4 特許請求の範囲第1項または第2項に記載の
硫酸エステルの製造法において、植物性多糖類が
トラガカントであることを特徴とする方法。[Scope of Claims] 1. A method for producing a vegetable polysaccharide sulfate ester, which comprises sulfuric esterifying a vegetable polysaccharide obtained from plant gums. 2. The method for producing a sulfuric acid ester according to claim 1, wherein the sulfuric acid esterification is carried out by reacting a vegetable polysaccharide with chlorosulfonic acid. 3. The method for producing a sulfuric ester according to claim 1 or 2, wherein the vegetable polysaccharide is arabin. 4. The method for producing a sulfuric ester according to claim 1 or 2, wherein the vegetable polysaccharide is tragacanth.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7657379A JPS56803A (en) | 1979-06-18 | 1979-06-18 | Preparation of vegetable polysaccharide sulfate ester |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7657379A JPS56803A (en) | 1979-06-18 | 1979-06-18 | Preparation of vegetable polysaccharide sulfate ester |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS56803A JPS56803A (en) | 1981-01-07 |
JPS6317842B2 true JPS6317842B2 (en) | 1988-04-15 |
Family
ID=13608976
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7657379A Granted JPS56803A (en) | 1979-06-18 | 1979-06-18 | Preparation of vegetable polysaccharide sulfate ester |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS56803A (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2538404B1 (en) * | 1982-12-28 | 1985-08-23 | Anic Spa | |
CN100404557C (en) * | 2005-12-09 | 2008-07-23 | 武汉理工大学 | Preparation method of umbellate pore fungus polysaccharide sulphate |
-
1979
- 1979-06-18 JP JP7657379A patent/JPS56803A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS56803A (en) | 1981-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4500519A (en) | Mucopolysaccharides having biological properties, preparation and method of use | |
US4981955A (en) | Depolymerization method of heparin | |
DE3102621C2 (en) | ||
WOOD JR et al. | Stevioside. I. The structure of the glucose moieties | |
EP0116801B1 (en) | Depolymerized and supersulfated heparin, process for its preparation and pharmaceutical compositions containing them | |
JPH0231081B2 (en) | ||
DE3734815C2 (en) | ||
ES2376409T3 (en) | NEW OLIGOSAC�? RIDOS, ITS PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
US6617316B1 (en) | Oligosaccharides, their preparation and pharmaceutical compositions containing them | |
EP0649602A2 (en) | Process for making soluble beet fibre | |
WO2018221547A1 (en) | Moisturizing topical preparation | |
US4524066A (en) | Process for the preparation of injectable chondroitin polysulfate | |
BR112019017527A2 (en) | POLYSULFATE PENTOSAN, PHARMACEUTICAL COMPOSITION, AND ANTICOAGULANT. | |
JP2006291028A (en) | Low-molecular heparin or salt thereof, and manufacturing method thereof | |
DK174284B1 (en) | Biologically active tetrasaccharides | |
DE3641833A1 (en) | CYTOSTATICALLY EFFECTIVE ANTHRACYCLINE DERIVATIVES | |
JPS6317842B2 (en) | ||
DE2814032C2 (en) | ||
Ford | A new lactone from water-stressed chickpea | |
Redgwell | Composition of Actinidia mucilage | |
DE602004012314T2 (en) | LOW-MOLECULAR POLYSACCHARIDES WITH ANTITHROMBOTIC EFFECT | |
DD297165A5 (en) | NEW SULFATED POLYSACCHARIDES, PHYSIOLOGICALLY TRANSLATED SALTS AND METHOD FOR THE PRODUCTION THEREOF | |
CN104725532B (en) | A kind of method of chondroitin sulfate and dermatan sulfate content in accurate quantification control heparin/heparan | |
US2871235A (en) | Process for obtaining polysaccharide material from plants of the genus cecropia | |
EP0301400A2 (en) | Oligosaccharide derivatives, their preparation and their use |